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The present work was to evaluate the anti-inﬂammatory activity of Delonix regia leaves (Family: Caesalpiniaceae). The powder
of Delonix regia leaves was subjected to extraction with ethanol in soxhlet extractor. The ethanol extract after preliminary
phytochemical investigation showed the presence of sterols, triterpenoids, phenolic compounds and ﬂavonoids. The anti-
inﬂammatory activity was studied using carrageenan-induced rat paw edema and cotton pellet granuloma at a three diﬀerent
doses (100, 200, and 400mg/kg b.w. p.o.) of ethanol extract. The ethanol extract of Delonix regia leaves was exhibited signiﬁcant
anti-inﬂammatory activity at the dose of 400mg/kg in both models when compared with control group. Indomethacin (10mg/kg
b.w. p.o) was also shown signiﬁcant anti-inﬂammatory activity in both models.
1.Introduction
Inﬂammation is a series of pathological changes associated
with local vascular reaction and cellular response, the
living tissue, an injury insuﬃcient to kill the tissue. This
is distinguished from the wider problem of generalized
reactions of the body. However, it is related to infection
causedbymicroorganisms,andvariouspathologicalchanges
are associated with it [1]. Traditional medicines play an
important role in health services around the globe. About
three-quarters of the world population relies on plants and
plant extracts for healthcare. The rational design of novel
drugs from traditional medicine oﬀers new prospects in
modern healthcare. Delonix regia ( B o j .E x .H o o k )( F a m i l y :
Caesalpiniaceae) is a medium-sized tree found in greater
parts of India. The decoction of the leaves is traditionally
used in treating gastric problems, body pain, and rheumatic
pains of joints [2, 3]. Ethanolic extracts of ﬂower and bark
were investigated to anti-inﬂammatory activity in rats [4].
T h el e a v e sa r er e p o r t e dt oa n t i b a c t e r i a l[ 5] and antimalarial
[6]. Delonix regia contains proteins, ﬂavonoids, tannins,
phenolic compounds, glycosides, sterols, and triterpenoids.
However, no data were found regarding the pharmacological
and phytochemical evaluation of the leaves of the plant.
The aim of the present study was to investigate the anti-
inﬂammatory activity of the ethanol extract of the leaves of
Delonix regia (Boj. Ex. Hook).
2.MaterialsandMethods
2.1. Plant Material. Delonix regia leaves were procured from
the local market in Jalgaon, Maharashtra, India, identiﬁed,
and authenticated. A voucher specimen (voucher specimen
number-Vaishu 9200) was deposited in the herbarium of
the Department of Botany, Rashtrasant Tukdoji Maharaj,
Nagpur University, Nagpur.
2.2.ExtractionofPlantMaterial. Theleavesweredriedunder
a shade and pulverized. The coarse powder (1000g) was
extracted with ethanol using a soxhlet apparatus. The extract
was dried using a rotary vacuum evaporator and stored in2 Advances in Pharmacological Sciences
a desiccatoruntilfurtheruse.Thepercentageyieldofethanol
extract of Delonix regia (EEDR) was 25.0%w/w.
2.3. Phytochemical Screening. A preliminary phytochemical
screening of Delonix regia was carried out [7]. The presence
of alkaloid (Dragendorﬀ reagent and Mayer’s reagent),
ﬂavonoids (Shinoda test), steroids (Liberman Burchard test),
and terpenes (Vanillin sulfuric acid reagent) were analyzed.
2.4. Drugs and Chemicals. Indomethacin was purchased
from Themis Pharmaceutical Ltd. India. Carrageenan was
purchased from Sigma Aldrich, USA. Tween 80 and other
reagents of analytical grade were purchased from S. D. Fine
Chem. Ltd, India.
2.5. Animals. Wistar albino rats (150–200g) and mice (20–
25g) of either sex were purchased from Calcutta Fish
Aquarium, Indore, India and were housed under standard
conditions of temperature and light. Animals had free
access to food (Amrut Feeds, Pune, India) and water.
The Institutional Animal Ethics Committee approved the
protocol of the study.
2.6. Acute Toxicity Studies. Healthy adult Swiss albino mice
of either sex weighing between 20 and 25g were subjected to
acute toxicity studies as per guidelines (AOT no. 425) sug-
gested by the Organization for Economic Cooperation and
Development[8].Groupsofsixmiceeachwereadministered
orallygradeddosesrangingfrom0.1to5g/kg.Themicewere
observed continuously for 2h for behavioral, neurological,
and autonomic proﬁles for any lethality or death for the next
48h.
2.7. Anti-Inﬂammatory Activity
2.7.1. Carrageenan-Induced Paw Edema. The anti-inﬂam-
matory activity of the extract was carried out using Wistar
albino rats (150–200g) of either sex [9, 10]. The rats were
divided into ﬁve groups of six rats each. The control group
received 1% (v/v) Tween 80 in water, p.o. at a dose of
10mL/kg. The positive control group was treated orally with
thestandarddrug,indomethacin(10mg/kg).Ethanolextract
was administered orally to the other groups in doses of 100,
200, and 400mg/kg as shown in Table 1. All the suspensions
were administered 30min before the induction of oedema
by administering 0.1mL of 1%w/v carrageenan in saline
[11, 12] .T h ed e g r e eo fp a wo e d e m ao fa l lt h eg r o u p sw a s
measured using a plethysmometer at 0, 1, 3, 5, and 7h after
the administration of carrageenan to each group.
2.8. Cotton Pellet Granuloma. Two autoclaved cotton pellets
weighing 10 ± 1mg were implanted subcutaneously into
both sides of the groin region of each rat. The rats were
divided into ﬁve groups of six rats each. The control group
received 1% (v/v) Tween 80 in water, p.o. at a dose of
10mL/kg. The positive control group was treated orally with
thestandarddrug,indomethacin(10mg/kg).Ethanolextract
was administered to the other groups in doses of 100, 200,
and 400mg/kg orally for 7 days. After 7 days, the animals
were sacriﬁced, and the pellets together with the granuloma
tissues were carefully removed, dried in an oven at 60◦C,
weighed, and compared with control [13].
2.9. Statistical Analysis. A l lv a l u e sa r ee x p r e s s e da sM e a n±
SEM. Statistical analysis was performed by one-way analysis
of Variance (ANOVA), and individual comparisons of the
group mean values were done using Dunnet’s t-test, with the
help of Graph Pad prism 4.0 software. The value of P lower
than 0.05 was considered as signiﬁcant (P is probability)
[14, 15].
3. Results
3.1. Phytochemical Studies. The preliminary phytochemical
studies of ethanol extract of Delonix regia was indicated the
presence of sterols, triterpenoids, phenolic compounds, and
ﬂavonoids.
3.2. Acute Toxicity Studies. In acute oral toxicity study, mice
given graded doses ranging from 0.1 to 5g/kg appeared nor-
mal.Delonixregiawassafeuptoadoselevelof5000mg/kgof
body weight. No lethality or any toxic reactions were found
up to the end of the study period.
3.3. Anti-inﬂammatory Activity
3.3.1. Carrageenan-Induced Paw Edema. The ethanol extract
(400mg/kg) signiﬁcantly inhibited carrageenan-induced
paw oedema. The ethanol extract produced a dose-
dependent inhibition of carrageenan oedema which was
comparable with known anti-inﬂammatory drugs. The
ethanol extract of Delonix regia produced signiﬁcant (P<
0.01) anti-inﬂammatory activity. Signiﬁcant reduction of
paw oedema was observed at 3h after carrageenan injection.
The reduction in carrageenan-induced paw oedema by
400mg/kg of ethanol extract after 3h was 48.1%, while
oedema reduction by the standard drug, indomethacin
(10mg/kg), was 65.8% (Table 1).
3.3.2. Cotton Pellet Granuloma. The ethanol extract signif-
icantly inhibited cotton pellet granuloma. The percent inhi-
bitionofethanolextractwas42.4%atdoseof400mg/kg,and
this inhibition was less than that produced by indomethacin
(61.6%) (Table 2).
4. Discussion
Carrageenan-induced oedema of rat foot is used widely as a
working model of inﬂammation in the search for new anti-
inﬂammatoryagents[16]andappearedtobethebasisforthe
discoveryofindomethacin,theanti-inﬂammatorydrug[17].
The oedema which develops in rat paw after carrageenan
injection is a biphasic event. The initial phase is attributed
to the release of histamine and serotonin, the oedema
maintained between the ﬁrst and second phase to kinin, andAdvances in Pharmacological Sciences 3
Table 1: Eﬀect of ethanol extract of Delonix regia (100, 200, and 400mg/kg) on paw volume in carrageenan-induced paw edema rats.
Treatment Dose mg kg−1 Carrageenan-induced rat paw edema Mean ± SEM∗
+1h +3h +5h +7h
Control — 0.36 ±0.06 0.79 ±0.05 0.64 ±0.04 0.68 ±0.01
Indomethacin 10 0.18 ±0.03a 0.27 ±0.04
(65.82)b
0.29 ±0.03
(54.68)b
0.33 ±0.06
(51.47)b
EEDR 100 0.28 ±0.02
(22.22)NS
0.46 ±0.03
(41.77)b
0.39 ±0.03
(39.06)b
0.41 ±0.03
(35.93)b
EEDR 200 0.25 ±0.01
(30.55)NS
0.43 ±0.01
(45.56)b
0.38 ±0.03
(40.62)b
0.39 ±0.03
(42.64)b
EEDR 400 0.21 ±0.02
(41.66)NS
0.41 ±0.02
(48.10)b
0.37 ±0.01
(42.18)b
0.4 ±0.01
(41.17)b
∗The number of animal was 6 in each group. Figure in parenthesis indicates percent inhibition in paw volume. The probability values were calculated using
one way ANOVA followed by Dunnet’s t-test: a < 0.05, b < 0.01, NS: not signiﬁcant.
Table 2: Eﬀe c to fe t h a n o le x t r a c to fDelonix regia (100, 200 and 400 mg/kg) on cotton pellet granuloma in rats.
Treatment Dose mg kg−1 Cotton pellet granuloma
Weight of pellets Mean ± SEM
Control 0.3mL 51.73 ± 2.35
Indomethacin 10 19.82 ±2.52 (61.68)b
EEDR 100 37.24 ±2.00 (27.99)NS
EEDR 200 30.85 ±3.72 (40.36)b
EEDR 400 29.77 ±3.76 (42.44)a
∗The number of animal was 6 in each group. Figure in parenthesis indicate percent inhibition in cotton pellet granuloma. The probability values were
calculated using one way ANOVA followed by Dunnet’s t-test: a < 0.05, b < 0.01, NS: not signiﬁcant.
the second phase to prostaglandin [18]. All the mediators
appear to be dependent upon an intact complement system
for their activation and release [19]. It has been shown that,
intheearlyphaseoftheoedema,thedominantcellsarepoly-
morphonuclears whereas in advanced stages mononuclears
predominate. In this study, indomethacin (nonsteroidal)
anti-inﬂammatory drug was tested on carrageenan oedema
[20]. Phytochemical studies on Delonix regia revealed that
it contains β-sitosterol, tannin, lupeol, and ﬂavonoids [21].
Hentriacontane, hentriacontanol and it’s D-glucoside, and
campesterol were identiﬁed as constituents of Delonix regia
[22].
Most of the anti-inﬂammatory triterpenes isolated have
lupane, oleanane, ursane, and taraxastane. Lupeol and
ursolic acid showed signiﬁcant anti-inﬂammatory activity
in various models [23, 24] .L u p e o lh a sb e e nr e p o r t e dt o
possess dose-dependent suppression of PGE2 without any
eﬀect of LTC4 release. Thus, ursolic acid and lupeol [25]
were able to prevent the production of some inﬂammatory
mediators which likely contributed to anti-inﬂammatory
eﬀect of Delonix regia. Jiang and Dusting have reported that
phenolic compounds have potential role in inﬂammatory
conditions [26]. Satya Prasad et al. have further shown
that phenolics inhibit polymorphonuclear lipoxygenase, an
enzyme involved in inﬂammatory conditions [27]. The
cotton pellet granuloma method has been widely employed
to assess the transductive, exudative, and proliferative com-
ponents of chronic inﬂammation and is a typical feature
of established chronic inﬂammatory reaction. The ﬂuid
absorbed by the pellet greatly inﬂuences the wet weight
of the granuloma, and dry weight correlates well with the
granuloma of the granulomatous tissue formed [28, 29].
Administration of ethanol extract at the doses of 400mg/kg
signiﬁcantly reduced the granulomatous tissue formation
when compared to control.
5. Conclusion
Preliminary phytochemical analysis indicated that the
ethanol extract of Delonix regia contains sterols, triter-
penoids, ﬂavonoids, and phenolic compounds. The anti-
inﬂammatory activity of ethanol extract of Delonix regia
may probably be due to the presence of several bioactive
anti-inﬂammatory principals. However, it needs isolation,
structural elucidation, and screening of any of the above-
mentioned active principle/s to pin point activity of drug.
It is thus apparent that ethanol extract of Delonix regia
possesses anti-inﬂammatory activity.
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